Skip to main content

Transmyocardial Laser Revascularization

  • Chapter
  • First Online:
Ischemic Heart Disease
  • 926 Accesses


It has been almost a decade since transmyocardial laser revascularization (TMR) was approved for clinical use. The safety of TMR was demonstrated initially with non-randomized studies in which TMR was used as the only treatment for patients with severe angina. TMR efficacy was proven after multiple randomized controlled trials. These revealed significant angina relief compared to maximum medical therapy in patients with diffuse coronary disease not amenable to conventional revascularization. In light of these results, TMR has been used as an adjunct to coronary artery bypass grafting (CABG). Even though TMR has to be implemented and tested to increase the therapeutic cohort, it represents a valid option as sole therapy and in combination with CABG. Further experiments will be carried out in association with other innovative newborn treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others



Bone marrow laser revascularization


Coronary artery bypass grafting


Coronary artery disease


Left internal mammary artery


Percutaneous coronary intervention


Transesophageal echocardiography


Transmyocardial laser revascularization


Vascular endothelial growth factor


  1. Muhkerjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis – how many patients might be eligible? Am J Cardiol. 1999;84:598–600.

    Article  Google Scholar 

  2. Weintraub WS, Jones EL, Craver JM, Guyton RA. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol. 1994;73:103–12.

    Article  CAS  PubMed  Google Scholar 

  3. Osswald BR, Blackstone EH, Tochtermann U, et al. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients? Eur J Cardiothorac Surg. 2001;20:120–6.

    Article  CAS  PubMed  Google Scholar 

  4. Allen KB. Holmium:YAG laser system for transmyocardial revascularization. Expert Rev Med Devices. 2006;3:137–46.

    Article  PubMed  Google Scholar 

  5. Lopes RD, Hafley GE, Allen KB, et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med. 2009;361:235–44.

    Article  CAS  PubMed  Google Scholar 

  6. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029–36. [PubMed: 10502592]

    Article  CAS  PubMed  Google Scholar 

  7. Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35(5):1170–7. [PubMed: 10758957]

    Article  CAS  PubMed  Google Scholar 

  8. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021–8. [PubMed: 10502591]

    Article  CAS  PubMed  Google Scholar 

  9. Jeevanandam V, Auteri JS, Oz MC, et al. Myocardial revascularization by laser-induced channels. Surg Forum. 1990;41:225–7.

    Google Scholar 

  10. Kwong KF, Kanellopoulos GK, Nikols JC, et al. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 1997;114:883–90. [PubMed: 9434682]

    Article  CAS  PubMed  Google Scholar 

  11. Horvath KA, Chiu E, Maun DC, et al. Up-regulation of VEGF mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg. 1999;68:825–9.

    Article  CAS  PubMed  Google Scholar 

  12. Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353:519–24.

    Article  CAS  PubMed  Google Scholar 

  13. Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet. 1999;354:885–90.

    Article  CAS  PubMed  Google Scholar 

  14. Cheng D, Diegeler A, Allen K, et al. Transmyocardial laser revascularization: a meta-analysis and systematic review of controlled trials. Innovations. 2006;1:295–313.

    Article  PubMed  Google Scholar 

  15. Allen KB, Dowling RD, Angell WW, et al. Transmyocardial revascularization: five-year follow-up of a prospective, randomized, multicenter trial. Ann Thorac Surg. 2004;77:1228–34.

    Article  PubMed  Google Scholar 

  16. Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540–9.

    Article  CAS  PubMed  Google Scholar 

  17. Frazier OH, Boyce SW, Griffith BP, et al. Transmyocardial revascularization using a synchronized CO2 laser as adjunct to coronary artery bypass grafting: results of a prospective, randomized multi-center trial with 12 month follow-up. Circulation. 1999;100:I248.

    Google Scholar 

Download references

Author information

Authors and Affiliations


Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zancanaro, E. (2023). Transmyocardial Laser Revascularization. In: Concistrè, G. (eds) Ischemic Heart Disease. Springer, Cham.

Download citation

  • DOI:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-25878-7

  • Online ISBN: 978-3-031-25879-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics